Page last updated: 2024-09-04

cyc 202 and Cancer of the Uterus

cyc 202 has been researched along with Cancer of the Uterus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coley, HM; Kokkinos, MI; Shotton, CF; Thomas, H	1

Other Studies

1 other study(ies) available for cyc 202 and Cancer of the Uterus

Article	Year
The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines. Gynecologic oncology, 2007, Volume: 105, Issue:2 Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cisplatin; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Female; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine; Sarcoma; Transcriptional Activation; Uterine Neoplasms	2007

Article

Year

The effects of the CDK inhibitor seliciclib alone or in combination with cisplatin in human uterine sarcoma cell lines.

Gynecologic oncology, 2007, Volume: 105, Issue:2

Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cisplatin; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Female; Flow Cytometry; Humans; Intracellular Signaling Peptides and Proteins; Protein Kinase Inhibitors; Purines; RNA, Messenger; Roscovitine; Sarcoma; Transcriptional Activation; Uterine Neoplasms

2007